Acute meningoencephalitis associated with SARS-CoV-2 infection in Colombia.

María A Palacio-Toro, Johan S Hernández-Botero, Daniela Duque-Montoya, Yuly Osorio, Alejandro Echeverry, Johanna J Osorio-Maldonado, Marcela Orjuela-Rodríguez, Alfonso J Rodríguez-Morales
Author Information
  1. María A Palacio-Toro: Universidad de Caldas, Manizales, Caldas, Colombia.
  2. Johan S Hernández-Botero: Grupo de Resistencia Antibiótica de Manizales (GRAM), Manizales, Caldas, Colombia.
  3. Daniela Duque-Montoya: Universidad de Caldas, Manizales, Caldas, Colombia.
  4. Yuly Osorio: Fundación Universitaria de Ciencias de La Salud, Bogotá, DC, Colombia.
  5. Alejandro Echeverry: Universidad de Caldas, Manizales, Caldas, Colombia.
  6. Johanna J Osorio-Maldonado: Universidad del Sinú, Cartagena, Bolivar, Colombia.
  7. Marcela Orjuela-Rodríguez: Universidad de Caldas, Manizales, Caldas, Colombia.
  8. Alfonso J Rodríguez-Morales: Latin American Network of COVID-19 Research (LANCOVID), Pereira, Risaralda, Colombia. alfonso.rodriguez@uam.edu.co. ORCID

Abstract

We present the case of a patient in the third decade of life, with asthma as comorbidity, who presented to the emergency department due to odynophagia, dyspnea, and cough of 2 days of evolution, later developing acute ventilatory failure requiring orotracheal intubation. The high-resolution chest tomography study showed consolidation due to a pneumonic process towards the posterior segment of the right lower lobe with areas of ground-glass infiltrates with a peripheral distribution. During the clinical course, the patient presented multiple seizure episodes that met the criteria for status epilepticus with MRI compatible with changes due to leptomeningitis. Given symptoms and thorax imaging, tests for SARS-CoV-2 ensued, with both positive RT-PCR in bronchoalveolar lavage and cerebrospinal fluid for the virus also positive. RT-PCR multiplex panel of meningitis/encephalitis results negative for 14 common organisms. A diagnosis of acute meningoencephalitis associated with COVID-19 was considered, with an adequate response to corticosteroid management; to our knowledge, this is the first adult patient with CNS involvement and CSF positive test in Latin America.

Keywords

References

  1. China CDC (2020). Centers for Disease Control and Prevention. China CDC Primers and Probes for Detection 2019-nCoV. Available online http://ivdc.chinacdc.cn/kyjz/202001/t20200121_211337.html (accessed on 24 Aug 2021)
  2. Corman V, Bleicker T, Brünink S, Drosten C, Zambon M (2020) Diagnostic detection of 2019-nCoV by real-time RT-PCR. World Health Organization 17:1–13
  3. Davies J, Randeva HS, Chatha K, Hall M, Spandidos DA, Karteris E, Kyrou I (2020) Neuropilin1 as a new potential SARSCoV2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID19. Mol Med Rep 22:4221–4226 [PMID: 33000221]
  4. Destras G, Bal A, Escuret V, Morfin F, Lina B, Josset L (2020) Systematic SARS-CoV-2 screening in cerebrospinal fluid during the COVID-19 pandemic. The Lancet Microbe 1:e149
  5. Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ (2020) Coronavirus disease 2019-COVID-19. Clin Microbiol Rev 33
  6. Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T (2020) Neurological associations of COVID-19. Lancet Neurol 19:767–783 [DOI: 10.1016/S1474-4422(20)30221-0]
  7. Etievant S, Bal A, Escuret V, Brengel-Pesce K, Bouscambert M, Cheynet V, Generenaz L, Oriol G, Destras G, Billaud G, Josset L, Frobert E, Morfin F, Gaymard A (2020) Performance assessment of SARS-CoV-2 PCR assays developed by WHO referral laboratories. J Clin Med 9
  8. Faico-Filho KS, Passarelli VC, Bellei N (2020) Is higher viral load in SARS-CoV-2 associated with death?. Am J Trop Med Hyg 103:2019–2021 [DOI: 10.4269/ajtmh.20-0954]
  9. Huo L, Xu KL, Wang H (2021) Clinical features of SARS-CoV-2-associated encephalitis and meningitis amid COVID-19 pandemic. World J Clin Cases 9:1058–1078 [DOI: 10.12998/wjcc.v9.i5.1058]
  10. Kremer S, Lersy F, de Seze J, Ferre JC, Maamar A, Carsin-Nicol B, Collange O, Bonneville F, Adam G, Martin-Blondel G, Rafiq M, Geeraerts T, Delamarre L, Grand S, Krainik A, Caillard S, Constans JM, Metanbou S, Heintz A, Helms J, Schenck M, Lefebvre N, Boutet C, Fabre X, Forestier G, de Beaurepaire I, Bornet G, Lacalm A, Oesterle H, Bolognini F, Messie J, Hmeydia G, Benzakoun J, Oppenheim C, Bapst B, Megdiche I, Henry Feugeas MC, Khalil A, Gaudemer A, Jager L, Nesser P, Talla Mba Y, Hemmert C, Feuerstein P, Sebag N, Carre S, Alleg M, Lecocq C, Schmitt E, Anxionnat R, Zhu F, Comby PO, Ricolfi F, Thouant P, Desal H, Boulouis G, Berge J, Kazemi A, Pyatigorskaya N, Lecler A, Saleme S, Edjlali-Goujon M, Kerleroux B, Zorn PE, Matthieu M, Baloglu S, Ardellier FD, Willaume T, Brisset JC, Boulay C, Mutschler V, Hansmann Y, Mertes PM, Schneider F, Fafi-Kremer S, Ohana M, Meziani F, David JS, Meyer N, Anheim M, Cotton F (2020) Brain MRI findings in severe COVID-19: a retrospective observational study. Radiology 297:E242–E251 [DOI: 10.1148/radiol.2020202222]
  11. Lewis A, Frontera J, Placantonakis DG, Lighter J, Galetta S, Balcer L, Melmed KR (2021) Cerebrospinal fluid in COVID-19: a systematic review of the literature. J Neurol Sci 421:117316
  12. Lucchese G (2020) Cerebrospinal fluid findings in COVID-19 indicate autoimmunity. Lancet Microbe 1:e242
  13. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, Chang J, Hong C, Zhou Y, Wang D, Miao X, Li Y, Hu B (2020) Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 77:683–690 [DOI: 10.1001/jamaneurol.2020.1127]
  14. Mohammadi A, Esmaeilzadeh E, Li Y, Bosch RJ, Li JZ (2020) SARS-CoV-2 detection in different respiratory sites: a systematic review and meta-analysis. EBioMedicine 59:102903
  15. Patrucco F, Albera C, Bellocchia M, Foci V, Gavelli F, Castello LM, Bellan M, Sainaghi PP, Airoldi C, Balbo PE, Solidoro P (2020) SARS-CoV-2 detection on bronchoalveolar lavage: an Italian multicenter experience. Respiration 99:970–978 [DOI: 10.1159/000511964]
  16. Pene F, Merlat A, Vabret A, Rozenberg F, Buzyn A, Dreyfus F, Cariou A, Freymuth F, Lebon P (2003) Coronavirus 229E-related pneumonia in immunocompromised patients. Clin Infect Dis 37:929–932 [DOI: 10.1086/377612]
  17. Taton O, Papleux E, Bondue B, Knoop C, Van Laethem S, Bauler A, Martiny D, Montesinos I, Delforge ML, Elmaouhab K, Leduc D (2020) Role of the bronchoalveolar lavage in noncritically Ill patients during the SARS-CoV-2 epidemic. Pulm Med 2020:9012187 [DOI: 10.1155/2020/9012187]
  18. Vargas-Gandica J, Winter D, Schnippe R, Rodriguez-Morales AG, Mondragon J, Escalera-Antezana JP, Trelles-Thorne MDP, Bonilla-Aldana DK, Rodriguez-Morales AJ, Paniz-Mondolfi A (2020) Ageusia and anosmia, a common sign of COVID-19? A case series from four countries. J Neurovirol 26:785–789 [DOI: 10.1007/s13365-020-00875-8]
  19. Zhang M, Zhou L, Wang J, Wang K, Wang Y, Pan X, Ma A (2020) The nervous system—a new territory being explored of SARS-CoV-2. J Clin Neurosci 82:87–92 [DOI: 10.1016/j.jocn.2020.10.056]

MeSH Term

Adult
COVID-19
Colombia
Humans
Meningoencephalitis
SARS-CoV-2
Seizures

Word Cloud

Created with Highcharts 10.0.0patientdueSARS-CoV-2positivepresentedacuteRT-PCRmeningoencephalitisassociatedCOVID-19Colombiapresentcasethirddecadelifeasthmacomorbidityemergencydepartmentodynophagiadyspneacough2 daysevolutionlaterdevelopingventilatoryfailurerequiringorotrachealintubationhigh-resolutionchesttomographystudyshowedconsolidationpneumonicprocesstowardsposteriorsegmentrightlowerlobeareasground-glassinfiltratesperipheraldistributionclinicalcoursemultipleseizureepisodesmetcriteriastatusepilepticusMRIcompatiblechangesleptomeningitisGivensymptomsthoraximagingtestsensuedbronchoalveolarlavagecerebrospinalfluidvirusalsomultiplexpanelmeningitis/encephalitisresultsnegative14commonorganismsdiagnosisconsideredadequateresponsecorticosteroidmanagementknowledgefirstadultCNSinvolvementCSFtestLatinAmericaAcuteinfectionEncephalitisSeizures

Similar Articles

Cited By